Legal & General Group
MRNS

Legal & General Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Legal & General Group’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,521
Closed -$49.9K – 3565
2024
Q1 		$49.9K Sell
5,521
-44
-0.8% -$428 ﹤0.01% 2778
2023
Q4 		$60.5K Sell
5,565
-159
-3% -$1.19K ﹤0.01% 2785
2023
Q3 		$46.1K Sell
5,724
-312
-5% -$2.6K ﹤0.01% 2874
2023
Q2 		$65.6K Buy
+6,036
New +$51.7K ﹤0.01% 2852
2022
Q2 		– Sell
-3,990
Closed -$37K – 3700
2022
Q1 		$37K Buy
3,990
+120
+3% +$1.19K ﹤0.01% 3069
2021
Q4 		$46K Sell
3,870
-34
-0.9% -$393 ﹤0.01% 3047
2021
Q3 		$44K Hold
3,904
– – ﹤0.01% 3016
2021
Q2 		$70K Buy
3,904
+755
+24% +$12.1K ﹤0.01% 2850
2021
Q1 		$49K Sell
3,149
-7,776
-71% -$112K ﹤0.01% 2819
2020
Q4 		$133K Buy
10,925
+7,949
+267% +$111K ﹤0.01% 2506
2020
Q3 		$38K Sell
2,976
-385
-11% -$3.32K ﹤0.01% 2782
2020
Q2 		$34K Buy
3,361
+95
+3% +$874 ﹤0.01% 2840
2020
Q1 		$27K Buy
3,266
+771
+31% +$6.68K ﹤0.01% 2807
2019
Q4 		$22K Buy
2,495
+481
+24% +$2.7K ﹤0.01% 3162
2019
Q3 		$12K Hold
2,014
– – ﹤0.01% 3246
2019
Q2 		$32K Hold
2,014
– – ﹤0.01% 2987
2019
Q1 		$34K Buy
2,014
+659
+49% +$9.49K ﹤0.01% 2875
2018
Q4 		$16K Hold
1,355
– – ﹤0.01% 3176
2018
Q3 		$54K Hold
1,355
– – ﹤0.01% 2736
2018
Q2 		$38K Buy
+1,355
New +$30K ﹤0.01% 2898

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's MRNS Position: Q2 2024 in Review

Legal & General Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 5,521 shares — an estimated $49.9K sold.

Legal & General Group first reported a position in MRNS in Q2 2018 and held it in 20 quarters. The position peaked at $133K in Q4 2020. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Legal & General Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 5,521 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $49.9K.
  • Legal & General Group first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 20 quarters.
  • Legal & General Group's Marinus Pharmaceuticals, Inc position peaked at $133K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.